Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN)

Historical Holders from Q4 2024 to Q3 2025

Type / Class
Equity / Ordinary shares, par value $0.0135 per share
Symbol
SLXN on Nasdaq
Shares outstanding
3,320,313
Price per share
$0.88
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
0
Total reported value
$0
Share change
-281,657
Value change
-$228,588
Number of holders
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CVI Investments, Inc. 4.9% -40% $424,574 +$109,304 456,531 +35% CVI Investments, Inc. 31 Mar 2025
Lind Global Fund III LP 6.4% -35% $187,000 -$10,164 212,500 -5.2% Lind Global Fund III LP 30 Sep 2025
GOLDMAN SACHS GROUP INC 2.4% -60% $197,109 +$92,724 211,945 +89% THE GOLDMAN SACHS GROUP, INC. 31 Mar 2025
INTRACOASTAL CAPITAL, LLC 5% $195,139 209,827 Mitchell P. Kopin 15 Jan 2025
Lincoln Alternative Strategies LLC 6.2% $115,500 131,250 Lincoln Alternative Strategies LLC 12 Sep 2025
Wildcat Capital Management, LLC 1.3% $108,891 113,428 Wildcat Capital Management, LLC 26 Jun 2025
As of 30 Sep 2025, Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN) has 0 institutional shareholders filing 13F forms. They reported no common stock holdings, but disclosed options positions.

Institutional Holders of Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 0 $0 -$228,588 $0.88 0
2025 Q2 281,657 $228,588 +$32,523 $0.81 6
2025 Q1 236,180 $259,798 +$95,688 $1.10 5
2024 Q4 140,169 $280,847 +$280,847 $2.01 3